Connect with us

Technology

40% of pharma executives are baking expected savings from Generative AI into 2024 budgets

Published

on

New survey from Bain & Company shows pharma executives are moving beyond AI experimentation to organization-wide scaling 

NEW YORK, Feb. 12, 2024 /PRNewswire/ — The generative artificial intelligence (AI) transformation is well underway in pharma, and pharma companies have high confidence in its value. Already, 40% of executives say they are baking expected savings into their 2024 budget, and 60% have set targets for cost savings or productivity boosts, according to a recent Bain & Company survey.

Nearly 60% of executives say that they have moved beyond ideation and brainstorming to building out use cases, with 55% reporting they expect to have multiple proof-of-concept or minimum viable product builds by the end of 2023.

“Over the next six to twelve months, leading companies will move from cultivating isolated pilots to scaling for results,” said Eric Berger, a partner in Bain & Company’s Healthcare & Life Sciences practice. “As leadership teams move beyond experimentation into pilots and launches, they are thinking carefully about when and how to communicate their AI journeys to investors. Those that can signal a structured, scalable enterprise-wide program, rather than a smattering of standalone initiatives, will reap the rewards in the next phase of AI.”

Data science and machine learning are not new to pharma executives who have been investing in productivity enhancements for years, primarily in the drug discovery space. Bain research shows 54% of pharma companies have automated biomedical literature review solutions, and 46% are using AI as part of their process to find potential disease targets. Now, generative AI is broadening the aperture of use cases with new opportunities across the value chain. Biomedical literature review and preclinical research remain among the most popular use case areas, although we’re also seeing high investment in IT and competitive intelligence. Within these top areas, more than 60% of executives say they have at least a proof of concept in development, and around 10% have already rolled out tools. These early adopters have moved swiftly, often reaching a working pilot within about eight weeks. Already, many are seeing tangible value.

Generative AI is top of mind for most pharma companies, with 75% citing it as a C-suite and board priority. And investors are watching closely to differentiate the pioneers from the followers. If pharma companies want to generate value from generative AI as fast as the technology allows, they need to ensure the organization is ready. Companies can take a three-tiered approach to prime their operating model for generative AI at scale:

Determine your strategic posture. Leading organizations will establish decision-making and funding models that prioritize high-return use cases, ensuring that those use cases fit within their investment themes around bold bets for the future of the business.Lead through change. Generative AI at scale requires strong internal leadership and cross-functional alignment. The best companies will establish an organizational center of gravity with several executives who act as generative AI champions.Build the foundations. In addition to the right technology, data, and models, generative AI at scale requires reorienting the organization to support big visions. This includes recruiting aggressively for data scientists to work on AI initiatives, building strategic partnerships with external vendors for support, and thoughtfully engaging on ethics and regulation by going a step further with a companywide risk management approach.

Editor’s Note: To arrange an interview, contact Katie Ware at katie.ware@bain.com or +1 646 562 8107. 

About Bain & Company

Bain & Company is a global consultancy that helps the world’s most ambitious change makers define the future.

Across 65 cities in 40 countries, we work alongside our clients as one team with a shared ambition to achieve extraordinary results, outperform the competition, and redefine industries. We complement our tailored, integrated expertise with a vibrant ecosystem of digital innovators to deliver better, faster, and more enduring outcomes. Our 10-year commitment to invest more than $1 billion in pro bono services brings our talent, expertise, and insight to organizations tackling today’s urgent challenges in education, racial equity, social justice, economic development, and the environment. We earned a platinum rating from EcoVadis, the leading platform for environmental, social, and ethical performance ratings for global supply chains, putting us in the top 1% of all companies. Since our founding in 1973, we have measured our success by the success of our clients, and we proudly maintain the highest level of client advocacy in the industry.

View original content to download multimedia:https://www.prnewswire.com/news-releases/40-of-pharma-executives-are-baking-expected-savings-from-generative-ai-into-2024-budgets-302059600.html

SOURCE Bain & Company

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

BRIDGE Appoints Morgan Jetto As Executive Vice President, Business Development & Ecosystems

Published

on

By

Industry Veteran to Lead Strategic Partnerships as BRIDGE Extends Its Position as the Trusted Partner for Audience Targeting, Curation, and Agentic Audience Targeting

NEW YORK, Apr. 21, 2026 /PRNewswire/ — BRIDGE, the verified people-data layer for advertising and marketing, today announced the appointment of Morgan Jetto as Executive Vice President, Business Development & Ecosystems. In this newly created role, Jetto will drive BRIDGE’s partnership strategy, expand its ecosystem of data and media integrations, and accelerate revenue growth across its key growth verticals as demand for verified data surges.

“Morgan brings a rare combination of deep industry relationships, strategic vision, and hands-on execution,” said Robert Rose, CEO of BRIDGE. “The industry is moving toward verified identity, curated audiences advertisers can trust, and agentic audience targeting that needs real, consent-audited people data underneath it. BRIDGE sits at the center of all three shifts, and Morgan’s leadership will help us extend that foundation to every agency, platform, and AI builder who needs it.”

Jetto joins BRIDGE from Verve Group, where he served as Senior Vice President and General Manager. His career spans nearly two decades of proven senior roles in AdTech and MarTech — including global partnerships at Yahoo, client leadership at GroupM, as well as board and advisory roles — with a consistent focus on building partnerships at the intersection of data, media, and emerging technology.

“BRIDGE has built something genuinely differentiated — a verified, people-based data foundation the industry urgently needs, and an architecture built for the next generation of agentic audience targeting,” said Jetto. “I’m excited to join at this critical and pivotal moment and help expand the ecosystem of partners, platforms, and clients who can benefit from the differentiated foundation BRIDGE has built— and I’m just getting started.”

BRIDGE is the verified people-data layer for advertising and marketing — the trusted foundation agencies, brands, platforms, and AI builders rely on for audience targeting and curation. Every record is a real person, verified through the Data Safe™ methodology. The CONNECT platform activates the same verified person across CTV, digital, social, email, audio, programmatic, and direct mail, and is built for agentic audience targeting through Connect MCP. People Match™ closes the loop with deterministic attribution. BRIDGE powers 160,000+ campaigns annually and has been ranked #1 for data accuracy by Truthset — an independent third party — for five consecutive years. The graph includes 412.9M verified consumers and business people and 679.8M permission-based emails, anchored on SOC2, SOC3, and HIPAA compliance. Learn more at www.thebridgecorp.com.

Media Contact

Karen Nordahl
BRIDGE
Director, Human Resources 
connect@thebridgecorp.com
+1 ( 212) 991-5633

View original content to download multimedia:https://www.prnewswire.com/news-releases/bridge-appoints-morgan-jetto-as-executive-vice-president-business-development–ecosystems-302749323.html

SOURCE BRIDGE

Continue Reading

Technology

SOLOWIN HOLDINGS Expects Revenue in the Range of $27 Million to $29 Million, Approximately 10x Year-over-Year Growth for the Fiscal Year Ended March 31, 2026 Based on Preliminary Unaudited Results

Published

on

By

HONG KONG, April 21, 2026 /PRNewswire/ — SOLOWIN HOLDINGS (Nasdaq: AXG) (“SOLOWIN,” the “Company,” or “we”), a leading financial technology firm bridging traditional and digital assets, today announced certain preliminary, unaudited financial results for the fiscal year ended March 31, 2026. Driven by the rapid expansion of its digital asset tokenization, stablecoin infrastructure, and AI-powered services, the Company delivered exceptional top-line growth for the fiscal year ended March 31, 2026, as it advances its global framework compliance and institutional-grade service strategy.

The preliminary financial results described in this press release are unaudited and based on management’s current estimates of our results for the fiscal year ended March 31, 2026. These figures are subject to the completion of our customary year-end financial closing procedures and audit by the Company’s independent registered public accounting firm. No assurance can be given that final audited results will not differ materially from these preliminary estimates, and any such differences could be significant. We expect to file our audited financial results for the fiscal year ended March 31, 2026, with the U.S. Securities and Exchange Commission in our Annual Report on Form 20-F, which is expected to be filed in July 2026.

Overall Performance

Revenue increased nearly tenfold year over year to between $27 million and $29 million for the fiscal year ended March 31, 2026.

Net loss was in the range of $11 million to $13 million, reflecting continued investment in technology, compliance, and global business expansion.

Financial Condition

As of March 31, 2026, cash and cash equivalents increased to between $14 million and $16 million.

Net cash used in operating activities was in the range of $12 million to $14 million for the year ended March 31, 2026. The increase in receivables from customers was the primary driver of the cash used in operating activities during the current period.

Net cash provided by investing activities was in the range of $1 million to $3 million for the year ended March 31, 2026, mainly consisting of cash and bank balances arising from acquisition of subsidiaries, partly offset by purchases of short-term investments.

Net cash provided by financing activities increased to between $18 million and $20 million for the year ended March 31, 2026, mainly representing the proceeds from capital injections from investors.

Strategic Overview

Against a backdrop of accelerating institutional adoption, maturing global regulation, and deepening integration of AI and blockchain, SOLOWIN has further consolidated its position as a fully compliant, vertically integrated digital financial platform, with a clear dual-token strategy focused on Digital Asset Tokens and AI Tokens. The Company’s ecosystem spans stablecoin issuance and payments, asset tokenization, securities trading and asset management, as well as AI-powered services.

Management Commentary

Mr. Lok Ling Ngai, Chief Executive Officer and Chairman of SOLOWIN, stated: “Fiscal 2026 marks a transformative year for SOLOWIN. Achieving tenfold revenue growth represents more than a financial milestone, it validates the strength of our dual-token strategy and underscores the accelerating global demand for compliant, institutional-grade digital asset infrastructure. We are uniquely positioned at the convergence of three structural shifts reshaping our industry: the advancement of regulatory frameworks, the rapid adoption of tokenization, and the integration of AI with blockchain technologies.”

“Guided by our mission ‘Mobilizing Tokens 24/7,’ we are building a secure, efficient, and fully regulated digital financial ecosystem. Over the past year, we have significantly strengthened and expanded our stablecoin and payment infrastructure, scaled our asset tokenization capabilities, and enhanced our AI-powered services. Together, these efforts reinforce and deepen our licensed platform advantages across Hong Kong, Bahrain, and other key global markets.”

“We see ourselves as more than a technology company — we are a trusted bridge connecting traditional finance and the decentralized economy. As global regulatory frameworks continue to mature and institutional adoption accelerates, we remain steadfast in our commitment to compliance, transparency, and responsible innovation. Our goal is to deliver sustainable, long-term value for our clients, partners, and shareholders — and help to power the future of finance.”

About SOLOWIN HOLDINGS

SOLOWIN HOLDINGS (NASDAQ: AXG) is a leading global regulated fintech company. Established in 2016, AXG combines blockchain and artificial intelligence technologies to operate a fully compliant dual-token digital economy super platform.

Guided by the mission “Mobilizing Tokens 24/7,” the Company focuses on tokenization and operates two core business pillars: Digital Asset Tokens and AI Tokens. Its offerings span stablecoin issuance and payments, asset tokenization, securities trading and asset management, as well as AI-powered services including cloud infrastructure, Know-Your-Agent verification, and token router.

Through its integrated ecosystem, including AXCOIN, AXONE, FERION, SOLOMON, SCION, and KOVAR, AXG empowers global institutions and investors to capitalize on the rapid growth of the dual-token economy.

For more information, visit the Company’s website at https://www.alloyx.com or Investor Relations webpage at https://ir.alloyx.com

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. The Company has attempted to identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other factors discussed in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”) including the “Risk Factors” section of the Company’s most recent Annual Report on Form 20-F as well as in its other reports filed or furnished from time to time with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC, which are available for review at www.sec.gov.

For investor and media inquiries please contact:

SOLOWIN HOLDINGS
Investor Relations Department
Email: ir@solowin.io

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com

View original content:https://www.prnewswire.com/news-releases/solowin-holdings-expects-revenue-in-the-range-of-27-million-to-29-million-approximately-10x-year-over-year-growth-for-the-fiscal-year-ended-march-31-2026-based-on-preliminary-unaudited-results-302749291.html

SOURCE SOLOWIN HOLDINGS

Continue Reading

Technology

Chemours Announces Dates for First Quarter 2026 Earnings Release and Webcast Conference Call

Published

on

By

WILMINGTON, Del., April 21, 2026 /PRNewswire/ — The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company expects to issue its first quarter 2026 financial results after market on Tuesday, May 5, 2026.

The Company expects to hold its conference call to discuss its first quarter 2026 financial results at 8:00 a.m. Eastern Time on Wednesday, May 6, 2026. The call is open to the public and can be accessed via the webcast information below. The webcast and materials can be accessed by visiting the “Events and Presentations” section of the Investor Relations section of Chemours’ website at investors.chemours.com.

Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides.

Replay: A webcast replay will be available at investors.chemours.com.

About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers’ biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700 employees and 28 manufacturing sites and serves approximately 2,400 customers in approximately 110 countries. For more information, visit chemours.com or follow us on LinkedIn

CONTACTS:

INVESTORS
Brandon Ontjes
Vice President, Head of Strategy & Investor Relations
+1.302.773.3300
investor@chemours.com

NEWS MEDIA
Cassie Olszewski
Media Relations & Reputation Leader
+1.302.219.7140
media@chemours.com  

View original content to download multimedia:https://www.prnewswire.com/news-releases/chemours-announces-dates-for-first-quarter-2026-earnings-release-and-webcast-conference-call-302749283.html

SOURCE The Chemours Company

Continue Reading

Trending